Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
18.19
-0.39 (-2.10%)
Jul 30, 2026, 3:40 PM HKT
HKG:1877 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, HKG:1877 stock has a consensus rating of "Buy" and an average price target of $28.86. The average 1-year stock price forecast is 58.66% higher than the current stock price, while the lowest is $20.01 (+10.01%) and the highest is $31.99 (+75.87%).
Price Target: $28.86 (+58.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:1877 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Buy Maintains $32.90 → $35.00 | Buy | Maintains | $32.90 → $35.00 | +92.41% | Jul 1, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $31.60 | Buy | Maintains | $31.60 | +73.72% | Apr 29, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $32.00 | Buy | Maintains | $32.00 | +75.92% | Mar 16, 2026 |
Financial Forecast
Revenue This Year
3.31B
from 2.50B
Increased by 32.35%
Revenue Next Year
4.10B
from 3.31B
Increased by 24.10%
EPS This Year
-0.59
from -0.42
EPS Next Year
-0.28
from -0.59
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.